Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
Condition: Lung Cancer Interventions: Drug: chemotherapy plus TCM 1&ICIs plusTCM2 placebo; Drug: chemotherapy plus TCM 1placebo&ICIs plus TCM2 placebo Sponsors: Shanghai University of Traditional Chinese Medicine; Shanghai Pulmonary Hospital, Shanghai, China; Shanghai Chest Hospital; Fudan University; Shanghai Zhongshan Hospital; Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials
